Byeong-Cheol Ahn

Author PubWeight™ 40.38‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 False-positive uptake on radioiodine whole-body scintigraphy: physiologic and pathologic variants unrelated to thyroid cancer. Am J Nucl Med Mol Imaging 2012 1.42
2 Incidental pituitary uptake on whole-body 18F-FDG PET/CT: a multicentre study. Eur J Nucl Med Mol Imaging 2010 1.35
3 The usefulness of F-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with Langerhans cell histiocytosis. Ann Nucl Med 2012 1.13
4 Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms. Thyroid 2013 1.08
5 Pulmonary amyloidosis mimicking multiple metastatic lesions on F-18 FDG PET/CT. Lung Cancer 2010 1.07
6 18F-FDG uptake by metastatic axillary lymph nodes on pretreatment PET/CT as a prognostic factor for recurrence in patients with invasive ductal breast cancer. J Nucl Med 2012 1.02
7 Prognostic value of whole-body metabolic tumour volume and total lesion glycolysis measured on ¹⁸F-FDG PET/CT in patients with extranodal NK/T-cell lymphoma. Eur J Nucl Med Mol Imaging 2013 0.96
8 Usefulness of SPECT/CT for equivocal findings on (131)I whole-body scan in a patient with differentiated papillary thyroid cancer. Clin Nucl Med 2014 0.90
9 Combined Cerenkov luminescence and nuclear imaging of radioiodine in the thyroid gland and thyroid cancer cells expressing sodium iodide symporter: initial feasibility study. Endocr J 2011 0.90
10 Dose-dependent frontal hypometabolism on FDG-PET in methamphetamine abusers. J Psychiatr Res 2009 0.89
11 Recurrence detection in differentiated thyroid cancer patients with elevated serum level of antithyroglobulin antibody: special emphasis on using (18)F-FDG PET/CT. Clin Endocrinol (Oxf) 2009 0.89
12 Bone scintigraphic findings of hypophosphatemic osteomalacia associated with adefovir therapy: involvement of lower extremity skeletons. Clin Nucl Med 2013 0.85
13 Enhanced antitumor effects by combination gene therapy using MDR1 gene shRNA and HSV1-tk in a xenograft mouse model. Cancer Lett 2009 0.85
14 Isolated facial muscle metastasis from renal cell carcinoma on F-18 FDG PET/CT. Clin Nucl Med 2010 0.84
15 Prognostic implications of microscopic involvement of surgical resection margin in patients with differentiated papillary thyroid cancer after high-dose radioactive iodine ablation. Ann Nucl Med 2012 0.83
16 Characterization of partial ligation-induced carotid atherosclerosis model using dual-modality molecular imaging in ApoE knock-out mice. PLoS One 2013 0.83
17 Peritoneal carcinomatosis in patients with ovarian cancer: enhanced CT versus 18F-FDG PET/CT. Clin Nucl Med 2013 0.82
18 Extra-thoracic tumor burden but not thoracic tumor burden on (18)F-FDG PET/CT is an independent prognostic biomarker for extensive-disease small cell lung cancer. Lung Cancer 2013 0.82
19 Dual reporter gene imaging for tracking macrophage migration using the human sodium iodide symporter and an enhanced firefly luciferase in a murine inflammation model. Mol Imaging Biol 2013 0.82
20 Targeting of hepatocellular carcinoma with glypican-3-targeting peptide ligand. J Pept Sci 2011 0.81
21 F-18 fluorodeoxyglucose PET/CT and post hoc PET/MRI in a case of primary meningeal melanomatosis. Korean J Radiol 2013 0.80
22 Prognostic Significance of Intratumoral Metabolic Heterogeneity on 18F-FDG PET/CT in Pathological N0 Non-Small Cell Lung Cancer. Clin Nucl Med 2015 0.79
23 A novel estrogen receptor intramolecular folding-based titratable transgene expression system. Mol Ther 2009 0.79
24 Superiority of delayed risk stratification in differentiated thyroid cancer after total thyroidectomy and radioactive iodine ablation. Nucl Med Commun 2014 0.79
25 Rituximab-induced pneumonitis on F-18 FDG PET/CT in patient with non-Hodgkin lymphoma. Clin Nucl Med 2010 0.79
26 Radioiodine SPET/CT guided needle aspiration as a useful technique for recurrence surveillance in a thyroidectomized differentiated thyroid cancer patient with negative US and serum Tg and positive Tg of the lymph node aspirate. Hell J Nucl Med 2013 0.79
27 Evaluation of the reversal of multidrug resistance by MDR1 ribonucleic acid interference in a human colon cancer model using a Renilla luciferase reporter gene and coelenterazine. Mol Imaging 2010 0.79
28 Combined RNA interference of hexokinase II and (131)I-sodium iodide symporter gene therapy for anaplastic thyroid carcinoma. J Nucl Med 2011 0.79
29 Intratumoral versus intravenous gene therapy using a transcriptionally targeted viral vector in an orthotopic hepatocellular carcinoma rat model. J Vasc Interv Radiol 2012 0.79
30 Enhanced scintigraphic visualization of thyroglossal duct remnant during hypothyroidism after total thyroidectomy: prevalence and clinical implication in patients with differentiated thyroid cancer. Thyroid 2007 0.79
31 Enhancement of natural killer cell cytotoxicity by sodium/iodide symporter gene-mediated radioiodine pretreatment in breast cancer cells. PLoS One 2013 0.79
32 Metabolic parameters using ¹⁸F-FDG PET/CT correlate with occult lymph node metastasis in squamous cell lung carcinoma. Eur J Nucl Med Mol Imaging 2014 0.79
33 Incidental detection of increased (18)F-FDG uptake and its follow-up in patients with granulomatous prostatitis after BCG treatment for urinary bladder cancer. Hell J Nucl Med 2014 0.79
34 Noninvasive imaging of apoptosis induced by adenovirus-mediated cancer gene therapy using a caspase-3 biosensor in living subjects. Mol Imaging 2014 0.79
35 In vivo monitoring of survival and proliferation of hair stem cells in a hair follicle generation animal model. Mol Imaging 2013 0.78
36 Prediction for recurrence using F-18 FDG PET/CT in pathologic N0 lung adenocarcinoma after curative surgery. Ann Surg Oncol 2013 0.78
37 Effect of parotid gland massage on parotid gland Tc-99m pertechnetate uptake. Thyroid 2012 0.78
38 18F-FDG PET/CT finding of bilateral primary breast mucosa-associated lymphoid tissue lymphoma. Clin Nucl Med 2015 0.78
39 Combined radionuclide-chemotherapy and in vivo imaging of hepatocellular carcinoma cells after transfection of a triple-gene construct, NIS, HSV1-sr39tk, and EGFP. Cancer Lett 2009 0.78
40 Human sodium iodide symporter added to multidrug resistance 1 small hairpin RNA in a single gene construct enhances the therapeutic effects of radioiodine in a nude mouse model of multidrug resistant colon cancer. Cancer Biother Radiopharm 2010 0.77
41 In vitro antiproliferative characteristics of flavonoids and diazepam on SNU-C4 colorectal adenocarcinoma cells. J Nat Med 2008 0.77
42 Emptying effect of massage on parotid gland radioiodine content. Nucl Med Commun 2014 0.77
43 Recurrence of a functional adrenocortical oncocytoma of borderline malignant potential showing high FDG uptake on 18F-FDG PET/CT. Ann Nucl Med 2013 0.77
44 Combined E7-dendritic cell-based immunotherapy and human sodium/iodide symporter radioiodine gene therapy with monitoring of antitumor effects by bioluminescent imaging in a mouse model of uterine cervical cancer. Cancer Biother Radiopharm 2011 0.76
45 Quantification of Intratumoral Metabolic Macroheterogeneity on 18F-FDG PET/CT and Its Prognostic Significance in Pathologic N0 Squamous Cell Lung Carcinoma. Clin Nucl Med 2016 0.76
46 Evaluation of kidney repair capacity using 99mTc-DMSA in ischemia/reperfusion injury models. Biochem Biophys Res Commun 2011 0.76
47 Clinical applications of SPECT/CT after first I-131 ablation in patients with differentiated thyroid cancer. Clin Endocrinol (Oxf) 2014 0.76
48 Macroaggregated albumin (MAA) injected in hepatic artery visualized in a recanalized paraumbilical vein. Clin Nucl Med 2012 0.75
49 Enhanced antiproliferative effects of combination hexokinase II shRNA and NIS gene therapy on vascular smooth muscle cells. Nucl Med Biol 2011 0.75
50 Estimation of external radiation dose to caregivers of patients treated with radioiodine after thyroidectomy. Health Phys 2014 0.75
51 Paradoxical exacerbation of preexisting Graves' disease induced by insufficient radioiodine treatment: a report of five patients. Nucl Med Commun 2009 0.75
52 Clinical outcomes of low-dose and high-dose postoperative radioiodine therapy in patients with intermediate-risk differentiated thyroid cancer. Nucl Med Commun 2016 0.75
53 Engineering of Radioiodine-Labeled Gold Core-Shell Nanoparticles As Efficient Nuclear Medicine Imaging Agents for Trafficking of Dendritic Cells. ACS Appl Mater Interfaces 2017 0.75
54 Bone marrow immunoscintigraphy using technetium-99m anti-granulocyte antibody in multiple myeloma. Eur J Nucl Med Mol Imaging 2002 0.75
55 Measurements and prediction of the ambient dose rate from patient receiving radioiodine administration after thyroid ablation. Radiat Prot Dosimetry 2011 0.75
56 Combined RNA interference of adenine nucleotide translocase-2 and ganciclovir therapy in hepatocellular carcinoma. Nucl Med Biol 2013 0.75
57 Corrigendum: Tracking of dendritic cell migration into lymph nodes using molecular imaging with sodium iodide symporter and enhanced firefly luciferase genes. Sci Rep 2015 0.75
58 Direct comparison of adenosine and adenosine 5'-triphosphate as pharmacologic stress agents in conjunction with Tl-201 SPECT: Hemodynamic response, myocardial tracer uptake, and size of perfusion defects in the same subjects. J Nucl Cardiol 2006 0.75
59 Prognostic Value of Volumetric Parameters Measured by Pretreatment 18F FDG PET/CT in Patients With Cutaneous Malignant Melanoma. Clin Nucl Med 2016 0.75
60 High and low radioiodine doses to indicate a simple renal cyst. Hell J Nucl Med 2012 0.75
61 Prognostic Value of Metabolic Parameters of 18F-FDG PET/CT and Apparent Diffusion Coefficient of MRI in Hepatocellular Carcinoma. Clin Nucl Med 2016 0.75
62 Solitary splenic metastasis from hepatocellular carcinoma detected on (18)F-FDG PET/CT. Clin Nucl Med 2015 0.75
63 Evaluation of hepatic function with (99m)Tc-galactosylated serum albumin scintigraphy in patients with malaria: comparison with (99m)Tc-colloid scintigraphy and liver ultrasonography. Nucl Med Commun 2007 0.75
64 Synthesis and evaluation of a radioiodinated bladder cancer specific peptide. Bioorg Med Chem 2012 0.75